Rarity Bioscience’s poster presentation at the Biomarkers 2024

Rarity Bioscience proudly engaged in the Biomarkers Congress 2024, presenting the poster ”Non-invasive patient stratification and treatment follow-up using ctDNA in colorectal cancer patients”

“Attending the Biomarkers UK 2024 conference proved to be a highly enriching and enlightening experience. I am happy to see that our superRCA ultra-sensitive technology improves many of the cumbersome problems of today regarding liquid biopsies, such as getting more data out of already small samples that are often of low quality and the issues around assay sensitivity”

The Poster

The poster delves deep into pioneering research exploring the potential of circulating tumor DNA (ctDNA) in plasma samples for patient stratification and treatment monitoring in colorectal cancer cases. Leveraging our ultra-sensitive superRCA technology and a 44-plex panel, we have achieved unmatched sensitivity in mutation detection with minimal sample input. 

We hope this will help reduce healthcare costs and improve early detection of disease relapse. 

Download the poster to delve deeper into this research and its potential impact.  

We would like to thank the organizers of the Biomarkers Congress 2024 for providing us with the platform to share our research and collaborate with industry peers. We would also like to give a huge thanks to all attendees who engaged with our poster presentation during the conference.

Share this article

Recommended articles